BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim WR, Lake JR, Smith JM, Schladt DP, Skeans MA, Harper AM, Wainright JL, Snyder JJ, Israni AK, Kasiske BL. OPTN/SRTR 2016 Annual Data Report: Liver. Am J Transplant 2018;18 Suppl 1:172-253. [PMID: 29292603 DOI: 10.1111/ajt.14559] [Cited by in Crossref: 238] [Cited by in F6Publishing: 199] [Article Influence: 79.3] [Reference Citation Analysis]
Number Citing Articles
1 Clément MA, Bosoi CR, Oliveira MM, Tremblay M, Bémeur C, Rose CF. Bile-duct ligation renders the brain susceptible to hypotension-induced neuronal degeneration: Implications of ammonia. J Neurochem 2021;157:561-73. [PMID: 33382098 DOI: 10.1111/jnc.15290] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou S, Mitsinikos T, Emamaullee J, Weaver C, Wang L, Shillingford N, Warren M, Bawab JH, Tiwari N, Genyk Y, Thomas D, Parham DM. Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation. Transplantation 2021;105:2045-53. [PMID: 33031223 DOI: 10.1097/TP.0000000000003469] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Madreseh E, Mahmoudi M, Nassiri-Toosi M, Baghfalaki T, Zeraati H. Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002-2019. Arch Iran Med 2020;23:326-34. [PMID: 32383617 DOI: 10.34172/aim.2020.22] [Reference Citation Analysis]
4 Pita A, Kaur N, Emamaullee J, Lo M, Nguyen B, Sabour A, Tristan V, Nadim M, Genyk Y, Sher L. Outcomes of Liver Transplantation in Patients on Renal Replacement Therapy: Considerations for Simultaneous Liver Kidney Transplantation Versus Safety Net. Transplant Direct 2019;5:e490. [PMID: 31723585 DOI: 10.1097/TXD.0000000000000935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
5 Aby ES, Lake JR. Basic principles of liver allocation and development over the years. Curr Opin Organ Transplant 2020;25:99-103. [PMID: 32073495 DOI: 10.1097/MOT.0000000000000732] [Reference Citation Analysis]
6 Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S. Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation. Clin Nutr 2020;39:1885-92. [PMID: 31481263 DOI: 10.1016/j.clnu.2019.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
7 Pozo-Laderas JC, Guler I, Rodríguez-Perálvarez M, Robles JC, Mula A, López-Cillero P, de la Fuente C. Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohort study. Med Intensiva (Engl Ed) 2021;45:395-410. [PMID: 34563340 DOI: 10.1016/j.medine.2020.02.004] [Reference Citation Analysis]
8 Papatheodoridi M, Mazza G, Pinzani M. Regenerative hepatology: In the quest for a modern prometheus? Dig Liver Dis 2020;52:1106-14. [PMID: 32868215 DOI: 10.1016/j.dld.2020.08.001] [Reference Citation Analysis]
9 Reid TD, Kratzke I, Dayal D, Raff L, Kumar A, Phillips MR, Carlson R, Desai CS. The role of extracorporeal membrane oxygenation in pediatric abdominal transplant patients: A qualitative systematic review of literature. Pediatr Transplant 2021;25:e13939. [PMID: 33314532 DOI: 10.1111/petr.13939] [Reference Citation Analysis]
10 Kelava T, Turcic P, Markotic A, Ostojic A, Sisl D, Mrzljak A. Importance of genetic polymorphisms in liver transplantation outcomes. World J Gastroenterol 2020; 26(12): 1273-1285 [PMID: 32256016 DOI: 10.3748/wjg.v26.i12.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Haugen CE, Ishaque T, Sapirstein A, Cauneac A, Segev DL, Gentry S. Geographic disparities in liver supply/demand ratio within fixed-distance and fixed-population circles. Am J Transplant 2019;19:2044-52. [PMID: 30748095 DOI: 10.1111/ajt.15297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Ko S, Russell JO, Molina LM, Monga SP. Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns. Annu Rev Pathol 2020;15:23-50. [PMID: 31399003 DOI: 10.1146/annurev-pathmechdis-012419-032824] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
13 Wellington J, Ma A, Kottilil S, Ravichandran B, Husson J, Bruno D, Wilson E. Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis. Viruses 2021;13:1831. [PMID: 34578412 DOI: 10.3390/v13091831] [Reference Citation Analysis]
14 Hwang CS, Macconmara M, Desai DM. Pediatric Abdominal Organ Transplantation. Surg Clin North Am 2019;99:73-85. [PMID: 30471743 DOI: 10.1016/j.suc.2018.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
15 Devcic Z, Toskich BB, Livingston D, Croome KP, Lewis AR, Ritchie C, Frey G, McKinney JM, Paz-Fumagalli R. Endovascular Treatment of Aortohepatic Conduit Stenosis Following Liver Transplant. Transplant Proc 2020;52:943-8. [PMID: 32139279 DOI: 10.1016/j.transproceed.2020.01.017] [Reference Citation Analysis]
16 Cullaro G, Verna EC, Emond JC, Orandi BJ, Mohan S, Lai JC. Early Kidney Allograft Failure After Simultaneous Liver-kidney Transplantation: Evidence for Utilization of the Safety Net? Transplantation 2021;105:816-23. [PMID: 32413016 DOI: 10.1097/TP.0000000000003310] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Rosenberg ES, Rosenthal EM, Hall EW, Barker L, Hofmeister MG, Sullivan PS, Dietz P, Mermin J, Ryerson AB. Prevalence of Hepatitis C Virus Infection in US States and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1:e186371. [PMID: 30646319 DOI: 10.1001/jamanetworkopen.2018.6371] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 21.0] [Reference Citation Analysis]
19 Bonou M, Mavrogeni S, Kapelios CJ, Skouloudi M, Aggeli C, Cholongitas E, Papatheodoridis G, Barbetseas J. Preoperative Evaluation of Coronary Artery Disease in Liver Transplant Candidates: Many Unanswered Questions in Clinical Practice. Diagnostics (Basel) 2021;11:75. [PMID: 33466478 DOI: 10.3390/diagnostics11010075] [Reference Citation Analysis]
20 Best LM, Leung J, Freeman SC, Sutton AJ, Cooper NJ, Milne EJ, Cowlin M, Payne A, Walshaw D, Thorburn D, Pavlov CS, Davidson BR, Tsochatzis E, Williams NR, Gurusamy KS. Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis. Cochrane Database Syst Rev 2020;1:CD013203. [PMID: 31978255 DOI: 10.1002/14651858.CD013203.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Massoud O. Hepatitis C: looking into the future. Expert Rev Gastroenterol Hepatol 2020;14:367-74. [PMID: 32216467 DOI: 10.1080/17474124.2020.1746641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Saraireh H, Sundaram LT, John BV. Biliary Strictures After Liver Transplantation with Grafts from Donors After Cardiac Death: Narrowing Down the Etiologies. Dig Dis Sci 2019;64:1736-7. [DOI: 10.1007/s10620-019-05589-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Murag S, Dennis BB, Kim D, Ahmed A, Cholankeril G. Recent advances in liver transplantation with HCV seropositive donors. F1000Res 2019;8:F1000 Faculty Rev-2151. [PMID: 31942236 DOI: 10.12688/f1000research.20387.1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Hecht EM, Kambadakone A, Griesemer AD, Fowler KJ, Wang ZJ, Heimbach JK, Fidler JL. Living Donor Liver Transplantation: Overview, Imaging Technique, and Diagnostic Considerations. AJR Am J Roentgenol 2019;213:54-64. [PMID: 30973783 DOI: 10.2214/AJR.18.21034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Galvin Z, Rajakumar R, Chen E, Adeyi O, Selzner M, Grant D, Sapisochin G, Greig P, Cattral M, McGilvray I, Ghanekar A, Selzner N, Lilly L, Patel K, Bhat M. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis. Liver Transpl. 2019;25:56-67. [PMID: 30609189 DOI: 10.1002/lt.25338] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
26 Grigg SE, Sarri GL, Gow PJ, Yeomans ND. Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma. Aliment Pharmacol Ther. 2019;49:1260-1273. [PMID: 30989721 DOI: 10.1111/apt.15253] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
27 Hemmersbach-Miller M, Wolfe CR, Schmader KE. Solid organ transplantation in older adults. Infectious and other age-related considerations. OBM Transplant 2019;3. [PMID: 34113803 DOI: 10.21926/obm.transplant.1901046] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Bittermann T, Hubbard RA, Lewis JD, Goldberg DS. The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes. Am J Transplant 2019;19:3319-27. [PMID: 31243887 DOI: 10.1111/ajt.15513] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
29 Jin T, Wang C, Tian Y, Dai C, Zhu Y, Xu F. Mitochondrial metabolic reprogramming: An important player in liver cancer progression. Cancer Lett 2020;470:197-203. [PMID: 31783085 DOI: 10.1016/j.canlet.2019.11.029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Luo X, Mogul DB, Massie AB, Ishaque T, Bridges JFP, Segev DL. Predicting chance of liver transplantation for pediatric wait-list candidates. Pediatr Transplant 2019;23:e13542. [PMID: 31313464 DOI: 10.1111/petr.13542] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Woelfel I, Gupta A, Renshaw S, Poulose B. Length of stay and surgical site complications are not increased after elective incisional hernia in patients with a history of solid organ transplantation. Surg Endosc 2021. [PMID: 33788030 DOI: 10.1007/s00464-021-08458-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Nagai S, Suzuki Y, Kitajima T, Ivanics T, Shimada S, Kuno Y, Shamaa MT, Yeddula S, Samaniego M, Collins K, Rizzari M, Yoshida A, Abouljoud M. Paradigm Change in Liver Transplantation Practice After the Implementation of the Liver-Kidney Allocation Policy. Liver Transpl 2021. [PMID: 34043869 DOI: 10.1002/lt.26107] [Reference Citation Analysis]
33 Hofmeister MG, Rosenthal EM, Barker LK, Rosenberg ES, Barranco MA, Hall EW, Edlin BR, Mermin J, Ward JW, Ryerson AB. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016. Hepatology 2019;69:1020-31. [PMID: 30398671 DOI: 10.1002/hep.30297] [Cited by in Crossref: 171] [Cited by in F6Publishing: 155] [Article Influence: 42.8] [Reference Citation Analysis]
34 Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson GE, Foley D, Mezrich JD, Kanmaz T, Andaçoğlu OM, D'Alessandro AM, Acarlı KS, Kalayoğlu M, Fernandez LA. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter. Turk J Med Sci 2021;51:610-22. [PMID: 33037873 DOI: 10.3906/sag-2007-82] [Reference Citation Analysis]
35 Park B, Yoon J, Kim HJ, Jung YK, Lee KG, Choi D. Transfusion Status in Liver and Kidney Transplantation Recipients-Results from Nationwide Claims Database. J Clin Med 2020;9:E3613. [PMID: 33182639 DOI: 10.3390/jcm9113613] [Reference Citation Analysis]
36 Cook M, Zavala E. The finances of a liver transplant program. Curr Opin Organ Transplant 2019;24:156-60. [PMID: 30694991 DOI: 10.1097/MOT.0000000000000612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Savier E, Brustia R, Golmard JL, Scatton O; Collaborators. Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation. J Visc Surg 2020;157:87-97. [PMID: 31548152 DOI: 10.1016/j.jviscsurg.2019.09.001] [Reference Citation Analysis]
38 Puia-Negulescu S, Lebossé F, Mabrut JY, Muller X, Rossignol G, Antonini T, Erard D, Radenne S, Guillet M, Souquet JC, Mohkam K, Lesurtel M. Liver Transplantation for Colorectal Liver Metastases: Current Management and Future Perspectives. Int J Mol Sci 2021;22:3093. [PMID: 33803503 DOI: 10.3390/ijms22063093] [Reference Citation Analysis]
39 Trapero-marugán M, Little EC, Berenguer M. Stretching the boundaries for liver transplant in the 21st century. The Lancet Gastroenterology & Hepatology 2018;3:803-11. [DOI: 10.1016/s2468-1253(18)30213-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
40 Shimels T, Getachew A, Tadesse M, Thompson A. Providers' View on the First Kidney Transplantation Center in Ethiopia: Experience From Past to Present. Health Serv Res Manag Epidemiol 2021;8:23333928211018335. [PMID: 34104678 DOI: 10.1177/23333928211018335] [Reference Citation Analysis]
41 Sposito C, Cucchetti A, Mazzaferro V. Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma. Dig Dis Sci 2019;64:1001-7. [DOI: 10.1007/s10620-019-05538-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
42 Brustia R, Dechartres A, Scatton O. A methodological review of clinical outcomes reported in liver transplantation trials. HPB (Oxford) 2020;22:833-44. [PMID: 31987738 DOI: 10.1016/j.hpb.2019.12.010] [Reference Citation Analysis]
43 Tian M, Wang B, Xue Z, Dong D, Liu X, Wu R, Yu L, Xiang J, Zhang X, Zhang X, Lv Y. Telemedicine for Follow-up Management of Patients After Liver Transplantation: Cohort Study. JMIR Med Inform 2021;9:e27175. [PMID: 33999008 DOI: 10.2196/27175] [Reference Citation Analysis]
44 Kwong AJ, Wall A, Melcher M, Wang U, Ahmed A, Subramanian A, Kwo PY. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors. Am J Transplant. 2019;19:1380-1387. [PMID: 30378723 DOI: 10.1111/ajt.15162] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 16.5] [Reference Citation Analysis]
45 Wang A, Jank I, Wei W, Schindler C, Dahmen U. A Novel Surgical Technique As a Foundation for In Vivo Partial Liver Engineering in Rat. J Vis Exp 2018. [PMID: 30346385 DOI: 10.3791/57991] [Reference Citation Analysis]
46 Voskanyan SE, Artemyev AI, Sushkov AI, Kolyshev IY, Rudakov VS, Shabalin MV, Naydenov EV, Maltseva AP, Svetlakova DS. Vascular reconstruction and outcomes of 220 adult-to-adult right lobe living donor liver transplantations. Alʹm klin med 2018;46:598-608. [DOI: 10.18786/2072-0505-2018-46-6-598-608] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
47 Talat S, Khan SA, Javed N, Malik MI. Etiology, clinical presentation, and outcome of children with fulminant hepatic failure: Experience from a tertiary center in Pakistan. Pak J Med Sci 2020;36:1252-6. [PMID: 32968389 DOI: 10.12669/pjms.36.6.2375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Kumar S, Lin S, Schold JD. Impact of donation after circulatory death donor allografts on outcomes following liver transplantation for fulminant hepatic failure in the United States. Am J Transplant 2021;21:382-90. [PMID: 32865321 DOI: 10.1111/ajt.16286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Kwong AJ, Mannalithara A, Heimbach J, Prentice MA, Kim WR. Migration of Patients for Liver Transplantation and Waitlist Outcomes. Clinical Gastroenterology and Hepatology 2019;17:2347-2355.e5. [DOI: 10.1016/j.cgh.2019.04.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
50 Kitajima T, Nagai S, Segal A, Magee M, Blackburn S, Ellithorpe D, Yeddula S, Qadeer Y, Yoshida A, Moonka D, Brown K, Abouljoud MS. Posttransplant Complications Predict Alcohol Relapse in Liver Transplant Recipients. Liver Transpl 2020;26:379-89. [DOI: 10.1002/lt.25712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
51 Lee TC, Dhar VK, Hoehn RS, Wima K, Kim Y, Ertel AE, Patel SH, Shah SA. Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes. Surgery 2019;166:1135-41. [DOI: 10.1016/j.surg.2019.06.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Watson CJE, Hunt F, Messer S, Currie I, Large S, Sutherland A, Crick K, Wigmore SJ, Fear C, Cornateanu S, Randle LV, Terrace JD, Upponi S, Taylor R, Allen E, Butler AJ, Oniscu GC. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant 2019;19:1745-58. [DOI: 10.1111/ajt.15241] [Cited by in Crossref: 68] [Cited by in F6Publishing: 54] [Article Influence: 22.7] [Reference Citation Analysis]
53 Bittermann T, Hubbard RA, Lewis JD, Goldberg DS. The proportion of Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications. Clin Transplant 2020;34:e13817. [PMID: 32027405 DOI: 10.1111/ctr.13817] [Reference Citation Analysis]
54 AdiwinataPawitan J. Exploring the Most Promising Stem Cell Therapy in Liver Failure: A Systematic Review. Stem Cells Int. 2019;2019:2782548. [PMID: 31871465 DOI: 10.1155/2019/2782548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
55 Jenssen T, Hartmann A. Post-transplant diabetes mellitus in patients with solid organ transplants. Nat Rev Endocrinol. 2019;15:172-188. [PMID: 30622369 DOI: 10.1038/s41574-018-0137-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 18.0] [Reference Citation Analysis]
56 Quintero J, Juampérez J, Mercadal-Hally M, Larrarte M, Vidal L, Castells L, Charco R. Transition to Adult Care for Pediatric Liver Transplant Recipients. Transplant Proc 2020;52:1496-9. [PMID: 32247593 DOI: 10.1016/j.transproceed.2020.02.056] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Park H, Jung ES, Lee MH, Lee JM. Organ Donation from Donors with Hepatitis B or C in South Korea: A 2013-2017 Nationwide Data Analysis. Ann Transplant 2021;26:e928947. [PMID: 33927178 DOI: 10.12659/AOT.928947] [Reference Citation Analysis]
58 Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology 2020;158:1851-64. [PMID: 32061595 DOI: 10.1053/j.gastro.2020.01.052] [Cited by in Crossref: 120] [Cited by in F6Publishing: 136] [Article Influence: 60.0] [Reference Citation Analysis]
59 Liu Y, Zhang Y, Ding Y, Chen G, Zhang X, Wang Y, Hua K. Clinical applications of uterus transplantation in China: Issues to take into consideration. J Obstet Gynaecol Res 2020;46:357-68. [DOI: 10.1111/jog.14199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Jain V, Bansal A, Radakovich N, Sharma V, Khan MZ, Harris K, Bachour S, Kleb C, Cywinski J, Argalious M, Quintini C, Menon KVN, Nair R, Tong M, Kapadia S, Fares M. Machine Learning Models to Predict Major Adverse Cardiovascular Events After Orthotopic Liver Transplantation: A Cohort Study. J Cardiothorac Vasc Anesth 2021;35:2063-9. [PMID: 33750661 DOI: 10.1053/j.jvca.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Gitto S, Aspite S, Golfieri L, Caputo F, Vizzutti F, Grandi S, Patussi V, Marra F. Alcohol use disorder and liver transplant: new perspectives and critical issues. Korean J Intern Med 2020;35:797-810. [PMID: 32241080 DOI: 10.3904/kjim.2019.409] [Reference Citation Analysis]
62 Keller J, Marklin G, Okoye O, Desai R, Sura T, Jain A, Varma C, Nazzal M. Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool. J Transplant 2021;2021:6612453. [PMID: 33564467 DOI: 10.1155/2021/6612453] [Reference Citation Analysis]
63 Asrani SK, Jennings LW, Kim W, Kamath PS, Levitsky J, Nadim MK, Testa G, Leise MD, Trotter JF, Klintmalm G. MELD‐GRAIL‐Na: Glomerular Filtration Rate and Mortality on Liver‐Transplant Waiting List. Hepatology 2020;71:1766-74. [DOI: 10.1002/hep.30932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
64 Xie H, Zhu H, Zhou K, Wan J, Zhang L, Yang Z, Zhou L, Chen X, Xu X, Zheng S, Wang H. Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival. Journal of Controlled Release 2020;328:237-50. [DOI: 10.1016/j.jconrel.2020.08.043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
65 Nair SP, Marella HK, Maliakkal B, Snyder H, Handley C, Kothadia JP, Ali B, Satapathy SK, Molnar MZ, Clark I, Jain R, Helmick R, Eymard C, Eason JD. Transplantation of liver from hepatitis C-infected donors to hepatitis C RNA-negative recipients: Histological and virologic outcome. Clin Transplant 2021;35:e14281. [PMID: 33690929 DOI: 10.1111/ctr.14281] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 McElroy LM, Likhitsup A, Scott Winder G, Saeed N, Hassan A, Sonnenday CJ, Fontana RJ, Mellinger J. Gender Disparities in Patients With Alcoholic Liver Disease Evaluated for Liver Transplantation. Transplantation 2020;104:293-8. [PMID: 31283683 DOI: 10.1097/TP.0000000000002843] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Weeks SR, Luo X, Toman L, Gurakar AO, Naqvi FF, Alqahtani SA, Philosophe B, Cameron AM, Desai NM, Ottmann SE, Segev DL, Garonzik-Wang J. Steroid-sparing maintenance immunosuppression is safe and effective after simultaneous liver-kidney transplantation. Clin Transplant 2020;34:e14036. [PMID: 32652700 DOI: 10.1111/ctr.14036] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
68 Dick AAS, Blondet NM, Shaw K, Healey PJ, Horslen S, Smith JM, Perkins JD, Reyes JD. The impact of public health service increased risk donors in pediatric liver transplantation. Pediatr Transplant 2020;24. [DOI: 10.1111/petr.13712] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Wadhwani SI, Hsu EK, Shaffer ML, Anand R, Ng VL, Bucuvalas JC. Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data. Pediatr Transplant 2019;23:e13554. [PMID: 31328849 DOI: 10.1111/petr.13554] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
70 Núñez K, Thevenot P, Alfadhli A, Cohen A. Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function. Int J Mol Sci 2018;19:E1750. [PMID: 29899265 DOI: 10.3390/ijms19061750] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
71 Cotter TG, Jensen DM. Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Des Devel Ther 2019;13:2565-77. [PMID: 31534310 DOI: 10.2147/DDDT.S172512] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
72 Carrier FM, Chassé M, Wang HT, Aslanian P, Bilodeau M, Turgeon AF. Effects of perioperative fluid management on postoperative outcomes in liver transplantation: a systematic review protocol. Syst Rev 2018;7:180. [PMID: 30382884 DOI: 10.1186/s13643-018-0841-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Lee BP, Terrault NA. Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise. Transl Gastroenterol Hepatol 2019;4:19. [PMID: 30976722 DOI: 10.21037/tgh.2019.03.04] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Cuenca AG, Hardy S, Shah U, Lawlor D, Ordulu Z, Sierra Velez D, Olshan K, Butler W, Yeh H. Pediatric liver transplant following near catastrophic head bleed: Lessons learned. Pediatr Transplant 2020;24:e13646. [PMID: 31960553 DOI: 10.1111/petr.13646] [Reference Citation Analysis]
75 Meraz-Muñoz A, García-Juárez I. Chronic kidney disease in liver transplantation: Evaluation of kidney function. Rev Gastroenterol Mex (Engl Ed) 2019;84:57-68. [PMID: 30612722 DOI: 10.1016/j.rgmx.2018.07.002] [Reference Citation Analysis]
76 Richards J, Gimson A, Joh Y, Watson CJE, Neuberger J. Trials & Tribulations of Liver Transplantation- are trials now prohibitive without surrogate endpoints? Liver Transpl 2021;27:747-55. [PMID: 33462951 DOI: 10.1002/lt.25988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Shah KY, Gaba RC. Combined Transarterial Chemoembolization and Percutaneous Radiofrequency Ablation: More Promising Evidence of Effectiveness in Treating Solitary, Medium-Sized Hepatocellular Carcinoma. J Vasc Interv Radiol 2019;30:1545-8. [PMID: 31547921 DOI: 10.1016/j.jvir.2019.07.005] [Reference Citation Analysis]
78 Ko S, Shin D. Chemical Screening Using a Zebrafish Model for Liver Progenitor Cell-Driven Liver Regeneration. Methods Mol Biol 2019;1905:83-90. [PMID: 30536092 DOI: 10.1007/978-1-4939-8961-4_8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
79 Del Bello A, Neau‐cransac M, Lavayssiere L, Dubois V, Congy‐jolivet N, Visentin J, Danjoux M, Le Bail B, Hervieu V, Boillot O, Antonini T, Kamar N, Dumortier J. Outcome of Liver Transplant Patients With Preformed Donor‐Specific Anti–Human Leukocyte Antigen Antibodies. Liver Transpl 2019;26:256-67. [DOI: 10.1002/lt.25663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
80 Emamaullee J, Kaur N, Sher L, Genyk Y. Use of Donation after Cardiac Death Donors at the University of Southern California. J Am Coll Surg 2019;229:437-8. [PMID: 31561801 DOI: 10.1016/j.jamcollsurg.2019.05.020] [Reference Citation Analysis]
81 Cucchetti A, Serenari M, Sposito C, Di Sandro S, Mosconi C, Vicentin I, Garanzini E, Mazzaferro V, De Carlis L, Golfieri R, Spreafico C, Vanzulli A, Buscemi V, Ravaioli M, Ercolani G, Pinna AD, Cescon M. Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant. Journal of Hepatology 2020;73:342-8. [DOI: 10.1016/j.jhep.2020.03.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
82 Zabala V, Boylan JM, Thevenot P, Frank A, Senthoor D, Iyengar V, Kim H, Cohen A, Gruppuso PA, Sanders JA. Transcriptional changes during hepatic ischemia-reperfusion in the rat. PLoS One 2019;14:e0227038. [PMID: 31891620 DOI: 10.1371/journal.pone.0227038] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
83 Elisofon SA, Magee JC, Ng VL, Horslen SP, Fioravanti V, Economides J, Erinjeri J, Anand R, Mazariegos GV, Dunn S, Martin A, Mannino D, Flynn L, Mohammad S, Alonso E, Superina R, Brandt K, Riordan M, Lokar J, Ito J, Elisofon S, Zapata L, Jain A, Foristal E, Gupta N, Whitlow C, Naik K, Espinosa H, Miethke A, Hawkins A, Hardy J, Engels E, Schreibeis A, Ovchinsky N, Kogan‐liberman D, Cunningham R, Malik P, Sundaram S, Feldman A, Garcia B, Yanni G, Kohli R, Emamaullee J, Secules C, Magee J, Lopez J, Bilhartz J, Hollenbeck J, Shaw B, Bartow C, Forest S, Rand E, Byrne A, Linguiti I, Wann L, Seidman C, Mazariegos G, Soltys K, Squires J, Kepler A, Vitola B, Telega G, Lerret S, Desai D, Moghe J, Cutright L, Daniel J, Andrews W, Fioravanti V, Slowik V, Cisneros R, Faseler M, Hufferd M, Kelly B, Sudan D, Mavis A, Moats L, Swan‐nesbit S, Yazigi N, Buranych A, Hobby A, Rao G, Maccaby B, Gopalareddy V, Boulware M, Ibrahim S, El Youssef M, Furuya K, Schatz A, Weckwerth J, Lovejoy C, Kasi N, Nadig S, Law M, Arnon R, Chu J, Bucuvalas J, Czurda M, Secheli B, Almy C, Haydel B, Lobritto S, Emand J, Biney‐amissah E, Gamino D, Gomez A, Himes R, Seal J, Stewart S, Bergeron J, Truxillo A, Lebel S, Davidson H, Book L, Ramstack D, Riley A, Jennings C, Horslen S, Hsu E, Wallace K, Turmelle Y, Nadler M, Postma S, Miloh T, Economides J, Timmons K, Ng V, Subramonian A, Dharmaraj B, Mcdiarmid S, Feist S, Rhee S, Perito E, Gallagher L, Smith K, Ebel N, Zerofsky M, Nogueira J, Greer R, Gilmour S, Robert C, Cars C, Azzam R, Boone P, Garbarino N, Lalonde M, Kerkar N, Dokus K, Helbig K, Grizzanti M, Tomiyama K, Cocking J, Alexopoulos S, Bhave C, Schillo R, Bailey A, Dulek D, Ramsey L, Ekong U, Valentino P, Hettiarachchi D, Tomlin R; the Society of Pediatric Liver Transplantation Research Group. Society of pediatric liver transplantation: Current registry status 2011‐2018. Pediatr Transplant 2020;24. [DOI: 10.1111/petr.13605] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
84 Richards JA, Sherif AE, Butler AJ, Hunt F, Allison M, Oniscu GC, Watson CJE. Model for early allograft function is predictive of early graft loss in donation after circulatory death liver transplantation. Clin Transplant 2020;34:e13982. [PMID: 32441409 DOI: 10.1111/ctr.13982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
85 Levitsky J, Asrani SK, Abecassis M, Ruiz R, Jennings LW, Klintmalm G. External Validation of a Pretransplant Biomarker Model (REVERSE) Predictive of Renal Recovery After Liver Transplantation. Hepatology 2019;70:1349-59. [DOI: 10.1002/hep.30667] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
86 Osho AA, Bishawi MM, Mulvihill MS, Axtell AL, Hirji SA, Spencer PJ, Heng EE, D'Alessandro DA, Melnitchouk S, Hartwig MG, Villavicencio MA. Failure to Rescue Contributes to Center-Level Differences in Mortality After Lung Transplantation. Ann Thorac Surg 2020;109:218-24. [PMID: 31470009 DOI: 10.1016/j.athoracsur.2019.07.013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
87 Arab JP, Izzy M, Leggio L, Bataller R, Shah VH. Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34725498 DOI: 10.1038/s41575-021-00527-0] [Reference Citation Analysis]
88 Abdulrahim N, Anderson L, Kotla S, Liu H, Ariyamuthu VK, Ghanta M, Macconmara M, Tujios SR, Mufti A, Mohan S, Marrero JA, Vagefi PA, Tanriover B. Lack of Benefit and Potential Harm of Induction Therapy in Simultaneous Liver-Kidney Transplants. Liver Transpl 2019;25:411-24. [DOI: 10.1002/lt.25390] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
89 Ferman TJ, Keaveny AP, Schneekloth T, Heckman MG, Vargas E, Vasquez A, Rummans T, Taner CB, Niazi SK. Liver Transplant Recipients Older Than 60 Years Show Executive and Memory Function Improvement Comparable to Younger Recipients. Psychosomatics 2019;60:488-98. [PMID: 30772017 DOI: 10.1016/j.psym.2019.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
90 Wanis KN, Madenci AL, Dokus MK, Tomiyama K, Al-judaibi BM, Hernán MA, Hernandez-alejandro R. The Effect of the Opioid Epidemic on Donation After Circulatory Death Transplantation Outcomes. Transplantation 2019;103:973-9. [DOI: 10.1097/tp.0000000000002467] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
91 Perito ER, Mogul DB, VanDerwerken D, Mazariegos G, Bucuvalas J, Book L, Horslen S, Kim HB, Miloh T, Ng V, Reyes J, Rodriguez-Davalos MI, Valentino PL, Gentry S, Hsu E. The Impact of Increased Allocation Priority for Children Awaiting Liver Transplant: A Liver Simulated Allocation Model (LSAM) Analysis. J Pediatr Gastroenterol Nutr 2019;68:472-9. [PMID: 30720563 DOI: 10.1097/MPG.0000000000002287] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
92 Goldaracena N, Barbas AS. Living donor liver transplantation. Curr Opin Organ Transplant. 2019;24:131-137. [PMID: 30694993 DOI: 10.1097/mot.0000000000000610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Fatourou EM, Tsochatzis EA. Management of metabolic syndrome and cardiovascular risk after liver transplantation. Lancet Gastroenterol Hepatol. 2019;4:731-741. [PMID: 31387736 DOI: 10.1016/s2468-1253(19)30181-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
94 Nagai S, Kitajima T, Yeddula S, Salgia R, Schilke R, Abouljoud MS, Moonka D. Effect of Mandatory 6-Month Waiting Period on Waitlist and Transplant Outcomes in Patients With Hepatocellular Carcinoma. Hepatology 2020;72:2051-62. [PMID: 32157711 DOI: 10.1002/hep.31223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ravaioli M, De Pace V, Angeletti A, Comai G, Vasuri F, Baldassarre M, Maroni L, Odaldi F, Fallani G, Caraceni P, Germinario G, Donadei C, Malvi D, Del Gaudio M, Bertuzzo VR, Siniscalchi A, Ranieri VM, D'Errico A, Pasquinelli G, Morelli MC, Pinna AD, Cescon M, La Manna G. Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial. Sci Rep 2020;10:6063. [PMID: 32269237 DOI: 10.1038/s41598-020-62979-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
96 Alcamo AM, Alessi LJ, Vehovic SN, Bansal N, Bond GJ, Carcillo JA, Green M, Michaels MG, Aneja RK. Severe Sepsis in Pediatric Liver Transplant Patients: The Emergence of Multidrug-Resistant Organisms. Pediatr Crit Care Med 2019;20:e326-32. [PMID: 31094887 DOI: 10.1097/PCC.0000000000001983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
97 Smith NK, Zerillo J, Schlichting N, Sakai T. Abdominal Organ Transplantation: Noteworthy Literature in 2018. Semin Cardiothorac Vasc Anesth 2019;23:188-204. [DOI: 10.1177/1089253219842655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Bobbert M, Primc N, Schäfer RN. Is there an ethical obligation to split every donor liver? Scarce resources, medical factors, and ethical reasoning. Pediatr Transplant 2019;23:e13534. [PMID: 31297945 DOI: 10.1111/petr.13534] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Ting PS, Hamilton JP, Gurakar A, Urrunaga NH, Ma M, Glorioso J, King E, Toman LP, Wesson R, Garonzik-Wang J, Ottmann S, Philosophe B, Sulkowski M, Cameron AM, Durand CM, Chen PH. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients. Transpl Infect Dis 2019;21:e13194. [PMID: 31609520 DOI: 10.1111/tid.13194] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
100 Matsushima H, Fujiki M, Sasaki K, Cywinski JB, D’amico G, Uso TD, Aucejo F, David Kwon CH, Eghtesad B, Miller C, Quintini C, Hashimoto K. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis. Surgery 2020;168:33-9. [DOI: 10.1016/j.surg.2020.02.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
101 Bhat M, Usmani SE, Azhie A, Woo M. Metabolic Consequences of Solid Organ Transplantation. Endocr Rev 2021;42:171-97. [PMID: 33247713 DOI: 10.1210/endrev/bnaa030] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Cotter TG, Dong L, Holmen J, Gilroy R, Krong J, Charlton M. Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system. J Gastroenterol 2020;55:722-30. [DOI: 10.1007/s00535-020-01684-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
103 Crismale JF, Khalid M, Bhansali A, De Boccardo G, Khaim R, Florman SS, Shapiro R, Schiano TD. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study. Clin Transplant 2020;34:e13761. [PMID: 31808193 DOI: 10.1111/ctr.13761] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
104 Santopaolo F, Lenci I, Bosa A, Angelico M, Milana M, Baiocchi L. Domino Liver Transplantation: Where are we Now? Rev Recent Clin Trials 2019;14:183-8. [PMID: 30894112 DOI: 10.2174/1574887114666190320123824] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
105 MacKay D, Fitz S. Geographic Location and Moral Arbitrariness in the Allocation of Donated Livers. J Law Med Ethics 2019;47:308-19. [PMID: 31298097 DOI: 10.1177/1073110519857287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
106 Kim J, Martin A, Yee J, Fojut L, Geurts AM, Oshima K, Zimmerman MA, Hong JC. Effects of Hepatic Ischemia-Reperfusion Injuries and NRF2 on Transcriptional Activities of Bile Transporters in Rats. J Surg Res 2019;235:73-82. [PMID: 30691853 DOI: 10.1016/j.jss.2018.09.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
107 Amer A, Wilson CH, Manas DM. Liver transplantation for unresectable malignancies: Beyond hepatocellular carcinoma. Eur J Surg Oncol 2019;45:2268-78. [PMID: 31387755 DOI: 10.1016/j.ejso.2019.07.024] [Reference Citation Analysis]
108 Claussen F, Gassner JMGV, Moosburner S, Wyrwal D, Nösser M, Tang P, Wegener L, Pohl J, Reutzel-Selke A, Arsenic R, Pratschke J, Sauer IM, Raschzok N. Dual versus single vessel normothermic ex vivo perfusion of rat liver grafts using metamizole for vasodilatation. PLoS One 2020;15:e0235635. [PMID: 32614897 DOI: 10.1371/journal.pone.0235635] [Reference Citation Analysis]
109 Shetty A, Buch A, Saab S. Use of Hepatitis C-Positive Liver Grafts in Hepatitis C-Negative Recipients. Dig Dis Sci 2019;64:1110-8. [PMID: 30560331 DOI: 10.1007/s10620-018-5404-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Schneekloth TD, Arab JP, Simonetto DA, Petterson TM, Niazi SK, Hall-Flavin DK, Karpyak VM, Kolla BP, Roth JE, Kremers WK, Rosen CB. Factors Having an Impact on Relapse and Survival in Transplant Recipients With Alcohol-Induced Liver Disease. Mayo Clin Proc Innov Qual Outcomes 2021;5:1153-64. [PMID: 34938953 DOI: 10.1016/j.mayocpiqo.2021.10.005] [Reference Citation Analysis]
111 Kwong AJ, Kim WR, Flemming JA. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology. 2018;68:1288-1297. [PMID: 29672886 DOI: 10.1002/hep.30045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
112 Kovac D, Choe J, Liu E, Scheffert J, Hedvat J, Anamisis A, Salerno D, Lange N, Jennings DL. Immunosuppression considerations in simultaneous organ transplant. Pharmacotherapy 2021;41:59-76. [PMID: 33325558 DOI: 10.1002/phar.2495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Kehar M, Parekh RS, Stunguris J, De Angelis M, Van Roestel K, Ghanekar A, Cattral M, Fecteau A, Ling S, Kamath BM, Jones N, Avitzur Y, Grant D, Ng VL. Superior Outcomes and Reduced Wait Times in Pediatric Recipients of Living Donor Liver Transplantation. Transplant Direct 2019;5:e430. [PMID: 30882035 DOI: 10.1097/TXD.0000000000000865] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
114 Covarrubias K, Luo X, Massie A, Schwarz KB, Garonzik-Wang J, Segev DL, Mogul DB. Determinants of length of stay after pediatric liver transplantation. Pediatr Transplant 2020;24:e13702. [PMID: 32212292 DOI: 10.1111/petr.13702] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
115 Seidita A, Longo R, Di Francesco F, Tropea A, Calamia S, Panarello G, Barbara M, Gruttadauria S. The use of normothermic machine perfusion to rescue liver allografts from expanded criteria donors. Updates Surg 2021. [PMID: 34542843 DOI: 10.1007/s13304-021-01169-2] [Reference Citation Analysis]
116 Cotter TG, Charlton MR. The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis: Hepatology. Hepatology 2019;69:931-3. [DOI: 10.1002/hep.30408] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
117 Del Bello A, Thaunat O, Le Quintrec M, Bestard O, Durrbach A, Perrin P, Gatault P, Jambon F, Pageaux GP, Llado L, Besch C, Barbier L, Neau-Cransac M, Dumortier J, Kamar N. Combined Liver-Kidney Transplantation With Preformed Anti-human Leukocyte Antigen Donor-Specific Antibodies. Kidney Int Rep 2020;5:2202-11. [PMID: 33305113 DOI: 10.1016/j.ekir.2020.09.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Schaffhausen CR, Bruin MJ, Chu S, McKinney WT, Lake JR, Chinnakotla S, Israni AK. Designing a Liver Transplant Patient and Family Decision Support Tool for Organ Offer Decisions. Transplant Direct 2021;7:e695. [PMID: 33937520 DOI: 10.1097/TXD.0000000000001140] [Reference Citation Analysis]
119 Mogul DB, Lee J, Purnell TS, Massie AB, Ishaque T, Segev DL, Bridges JFP. Barriers to access in pediatric living‐donor liver transplantation. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
120 Nikeghbalian S, Malekhosseini SA, Kazemi K, Arasteh P, Eghlimi H, Shamsaeefar A, Nikoupour H, Gholami S, Dehghani M, Dehghani SM, Bahador A, Salahi H. The Largest Single Center Report on Pediatric Liver Transplantation: Experiences and Lessons Learned. Ann Surg 2021;273:e70-2. [PMID: 32541224 DOI: 10.1097/SLA.0000000000004047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Brown S, Savva Y, Barth R, Lamattina J, Thuluvath PJ. Multiple Regional Listing Increases Liver Transplant Rates for Those With Model for End-stage Liver Disease Score <15. Transplantation 2020;104:762-9. [DOI: 10.1097/tp.0000000000002965] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Weeks SR, Luo X, Haugen CE, Ottmann SE, Gurakar AO, Naqvi FF, Alqahtani SA, Philosophe B, Cameron AM, Desai NM, Segev DL, Garonzik Wang JM. Delayed Graft Function in Simultaneous Liver Kidney Transplantation. Transplantation 2020;104:542-50. [PMID: 31403551 DOI: 10.1097/TP.0000000000002908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
123 Bowring MG, Massie AB, Chu NM, Bae S, Schwarz KB, Cameron AM, Bridges JFP, Segev DL, Mogul DB. Projected 20- and 30-Year Outcomes for Pediatric Liver Transplant Recipients in the United States. J Pediatr Gastroenterol Nutr 2020;70:356-63. [PMID: 31880667 DOI: 10.1097/MPG.0000000000002592] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Gurusamy KS, Tsochatzis E; Cochrane Hepato-Biliary Group. Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013203] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
125 Crismale JF, Ahmad J. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation. World J Gastroenterol 2019; 25(47): 6799-6812 [PMID: 31885421 DOI: 10.3748/wjg.v25.i47.6799] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
126 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
127 Cahalane AM, Mojtahed A, Sahani DV, Elias N, Kambadakone AR. Pre-hepatic and pre-pancreatic transplant donor evaluation. Cardiovasc Diagn Ther 2019;9:S97-S115. [PMID: 31559157 DOI: 10.21037/cdt.2018.09.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
128 Li X, Ma N, Xu J, Zhang Y, Yang P, Su X, Xing Y, An N, Yang F, Zhang G, Zhang L, Xing Y. Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury. Oxid Med Cell Longev 2021;2021:1587922. [PMID: 34745412 DOI: 10.1155/2021/1587922] [Reference Citation Analysis]
129 Nostedt JJ, Churchill T, Ghosh S, Thiesen A, Hopkins J, Lees MC, Adam B, Freed DH, Shapiro AMJ, Bigam DL. Avoiding initial hypothermia does not improve liver graft quality in a porcine donation after circulatory death (DCD) model of normothermic perfusion. PLoS One 2019;14:e0220786. [PMID: 31386697 DOI: 10.1371/journal.pone.0220786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
130 Ayloo S, Guss C, Pentakota SR, Hanna J, Molinari M. Minimally Invasive Sleeve Gastrectomy as a Surgical Treatment for Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Transplant Proc 2020;52:276-83. [PMID: 31889539 DOI: 10.1016/j.transproceed.2019.11.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
131 Finotti M, Auricchio P, Vitale A, Gringeri E, Cillo U. Liver transplantation for rare liver diseases and rare indications for liver transplant. Transl Gastroenterol Hepatol 2021;6:27. [PMID: 33824931 DOI: 10.21037/tgh-19-282] [Reference Citation Analysis]
132 Marroni CA, Fleck Jr AM, Fernandes SA, Galant LH, Mucenic M, de Mattos Meine MH, Mariante-Neto G, Brandão ABM. Liver transplantation and alcoholic liver disease: History, controversies, and considerations. World J Gastroenterol 2018; 24(26): 2785-2805 [PMID: 30018475 DOI: 10.3748/wjg.v24.i26.2785] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 32] [Article Influence: 11.8] [Reference Citation Analysis]
133 Lo AL, Sonnenberg EM, Abt PL. Evolving swaps in transplantation: global exchange, vouchers, liver, and trans-organ paired exchange. Curr Opin Organ Transplant 2019;24:161-6. [PMID: 30730354 DOI: 10.1097/MOT.0000000000000621] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
134 Pozo-laderas J, Guler I, Rodríguez-perálvarez M, Robles J, Mula A, López-cillero P, de la Fuente C. Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohort study. Medicina Intensiva 2021;45:395-410. [DOI: 10.1016/j.medin.2020.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Mergental H, Laing RW, Kirkham AJ, Perera MTPR, Boteon YL, Attard J, Barton D, Curbishley S, Wilkhu M, Neil DAH, Hübscher SG, Muiesan P, Isaac JR, Roberts KJ, Abradelo M, Schlegel A, Ferguson J, Cilliers H, Bion J, Adams DH, Morris C, Friend PJ, Yap C, Afford SC, Mirza DF. Transplantation of discarded livers following viability testing with normothermic machine perfusion.Nat Commun. 2020;11:2939. [PMID: 32546694 DOI: 10.1038/s41467-020-16251-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 24.5] [Reference Citation Analysis]
136 Wang S, Toy M, Hang Pham TT, So S. Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019. PLoS One 2020;15:e0239393. [PMID: 32946502 DOI: 10.1371/journal.pone.0239393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
137 Lee BP, Im GY, Rice JP, Lazar A, Weinberg E, Han H, Maddur H, Ghobrial RM, Therapondos G, Hsu C, Fix OK, Eswaran S, Shetty K, Chhatwal J, Dalgic OO, Jakhete N, Mobley C, Victor DW, Mehta N, Dinges L, Rinella M, Schiano TD, Lucey MR, Terrault N. Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31558-5. [PMID: 33279780 DOI: 10.1016/j.cgh.2020.11.024] [Reference Citation Analysis]
138 Holzner ML, Florman S, Schwartz ME, Tabrizian P. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma. HPB (Oxford) 2021:S1365-182X(21)01587-2. [PMID: 34544629 DOI: 10.1016/j.hpb.2021.08.943] [Reference Citation Analysis]
139 Safhi MA, Alzahrani M, Altahini KW, Kilfaden A, Bagber AA, Algethami MR, Jamal W, Rizk H. The Perception of Medical Students at King Abdulaziz University Hospital Regarding the Liver Transplant Allocation System. Cureus 2019;11:e6187. [PMID: 31886086 DOI: 10.7759/cureus.6187] [Reference Citation Analysis]
140 Lim RHG, Liew JXK, Wee A, Masilamani J, Chang SKY, Phan TT. Safety Evaluation of Human Cord-Lining Epithelial Stem Cells Transplantation for Liver Regeneration in a Porcine Model. Cell Transplant 2020;29:963689719896559. [PMID: 32166974 DOI: 10.1177/0963689719896559] [Reference Citation Analysis]
141 Han JL, Beal EW, Mumtaz K, Washburn K, Black SM. Combined liver-lung transplantation: Indications, outcomes, current experience and ethical Issues. Transplantation Reviews 2019;33:99-106. [DOI: 10.1016/j.trre.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
142 Tchilikidi KY. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion. World J Gastrointest Surg 2019; 11(3): 126-142 [PMID: 31057698 DOI: 10.4240/wjgs.v11.i3.126] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
143 Ko D, Bratzke LC, Muehrer RJ, Brown RL. Self-management in liver transplantation. Appl Nurs Res 2019;45:30-8. [PMID: 30683248 DOI: 10.1016/j.apnr.2018.11.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
144 Dayton KA, Bril F, Barb D, Lai J, Kalavalapalli S, Cusi K. Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes. PLoS One 2021;16:e0251449. [PMID: 34077443 DOI: 10.1371/journal.pone.0251449] [Reference Citation Analysis]
145 Sandmann L, Dörge P, Wranke A, Vermehren J, Welzel TM, Berg CP, Grottenthaler JM, Weiss KH, Langel J, Sterneck M, von Wulffen M, Manns MP, Wedemeyer H, Hardtke S, von Hahn T. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers. Eur J Gastroenterol Hepatol 2019;31:1049-56. [PMID: 30807443 DOI: 10.1097/MEG.0000000000001386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Dumortier J, Duvoux C, Dubel L, Bazin F, Houssel-Debry P. A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study. Ann Transplant 2019;24:506-16. [PMID: 31451681 DOI: 10.12659/AOT.916041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Jain AK, Anand R, Lerret S, Yanni G, Chen JY, Mohammad S, Doyle M, Telega G, Horslen S. Outcomes following liver transplantation in young infants: Data from the SPLIT registry. Am J Transplant 2021;21:1113-27. [PMID: 32767649 DOI: 10.1111/ajt.16236] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
148 Riveros S, Marino C, Ochoa G, Morales E, Soto D, Alegría L, Zenteno MJ, Brañes A, Achurra P, Rebolledo RA. Implementation and design of customized ex vivo machine perfusion. Analysis of its first results. Artif Organs 2021. [PMID: 34519358 DOI: 10.1111/aor.14060] [Reference Citation Analysis]
149 Ozdogan E, Doganay L, Can D, Arikan C. Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up. Am J Gastroenterol 2021;116:188-97. [PMID: 33065587 DOI: 10.14309/ajg.0000000000000934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
150 Gómez‐massa E, Talayero P, Utrero‐rico A, Laguna‐goya R, Andrés A, Mancebo E, Leivas A, Polanco‐fernández N, Justo I, Jimenez‐romero C, Pleguezuelo D, Paz‐artal E. Number and function of circulatory helper innate lymphoid cells are unaffected by immunosuppressive drugs used in solid organ recipients – a single centre cohort study. Transpl Int 2020;33:402-13. [DOI: 10.1111/tri.13567] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
151 Nagai S, Collins K, Chau LC, Safwan M, Rizzari M, Yoshida A, Abouljoud MS, Moonka D. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies. Clinical Gastroenterology and Hepatology 2019;17:2759-2768.e5. [DOI: 10.1016/j.cgh.2019.04.033] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
152 Palchevskiy V, Xue YY, Kern R, Weigt SS, Gregson AL, Song SX, Fishbein MC, Hogaboam CM, Sayah DM, Lynch JP 3rd, Keane MP, Brooks DG, Belperio JA. CCR4 expression on host T cells is a driver for alloreactive responses and lung rejection. JCI Insight 2019;5:121782. [PMID: 31085832 DOI: 10.1172/jci.insight.121782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Zori A, Villanueva F, Hatamleh D, Ismael M, Forde J, Mota M, Johnson L, Cabrera R. Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial. Dig Dis Sci 2021;66:628-35. [PMID: 32219612 DOI: 10.1007/s10620-020-06201-w] [Reference Citation Analysis]
154 De Bruyn P, Van Gestel D, Ost P, Kruse V, Brochez L, Van Vlierberghe H, Devresse A, del Marmol V, Le Moine A, Aspeslagh S. Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go? Current Opinion in Oncology 2019;31:54-64. [DOI: 10.1097/cco.0000000000000505] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 11.3] [Reference Citation Analysis]
155 Baganate F, Beal EW, Tumin D, Azoulay D, Mumtaz K, Black SM, Washburn K, Pawlik TM. Early mortality after liver transplantation: Defining the course and the cause. Surgery 2018;164:694-704. [DOI: 10.1016/j.surg.2018.04.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
156 Nagai S, Chau LC, Kitajima T, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Moonka D. A Share 21 model in liver transplantation: Impact on waitlist outcomes. Am J Transplant 2020;20:2184-97. [PMID: 32155314 DOI: 10.1111/ajt.15836] [Reference Citation Analysis]
157 Centonze L, Di Sandro S, Lauterio A, De Carlis R, Sgrazzutti C, Ciulli C, Vella I, Vicentin I, Incarbone N, Bagnardi V, Vanzulli A, De Carlis L. A retrospective single-centre analysis of the oncological impact of LI-RADS classification applied to Metroticket 2.0 calculator in liver transplantation: every nodule matters. Transpl Int 2021;34:1712-21. [PMID: 34448275 DOI: 10.1111/tri.13983] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
158 Covvey JR, Mancl EE. Pharmaceutical care in transplantation: current challenges and future opportunities. Nanomedicine (Lond) 2019;14:2651-8. [PMID: 31610735 DOI: 10.2217/nnm-2019-0106] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Brigham MD, Milgroom A, Lenco MO, Wang Z, Kent JD, LaMoreaux B, Johnson RJ, Mandell BF, Hadker N, Sanchez H, Francis K, Radeck LP, Miyasato G, Li JW. Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation Population. Prog Transplant 2020;30:103-10. [PMID: 32208882 DOI: 10.1177/1526924820913514] [Reference Citation Analysis]
160 Piemonti L, Sordi V, Pellegrini S, Scotti GM, Scavini M, Sioli V, Gianelli Castiglione A, Cardillo M. Circulating CXCL10 and IL-6 in solid organ donors after brain death predict graft outcomes. Sci Rep 2021;11:6624. [PMID: 33758270 DOI: 10.1038/s41598-021-86085-6] [Reference Citation Analysis]
161 Molinari M, Fernandez-Carrillo C, Dai D, Dana J, Clemente-Sanchez A, Dharmayan S, Kaltenmeier C, Liu H, Behari J, Rachakonda V, Ganesh S, Hughes C, Tevar A, Al Harakeh H, Emmanuel B, Humar A, Bataller R. Portal vein thrombosis and renal dysfunction: a national comparative study of liver transplant recipients for NAFLD versus alcoholic cirrhosis. Transpl Int 2021;34:1105-22. [PMID: 33780554 DOI: 10.1111/tri.13873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Wallace D, Cowling TE, Walker K, Suddle A, Rowe I, Callaghan C, Gimson A, Bernal W, Heaton N, van der Meulen J. Short- and long-term mortality after liver transplantation in patients with and without hepatocellular carcinoma in the UK. British Journal of Surgery 2020;107:896-905. [DOI: 10.1002/bjs.11451] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
163 Montenovo MI, Bambha K, Reyes J, Dick A, Perkins J, Healey P. Living liver donation improves patient and graft survival in the pediatric population: XXXX. Pediatr Transplant 2019;23:e13318. [DOI: 10.1111/petr.13318] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
164 Tejedor-Tejada J, Alonso-Martín C, Almohalla-Álvarez C, Valenzuela EF, Muñoz RN, Delgado LS, Martín CM, Sánchez-Martín F, García-Pajares F, Sánchez-Antolín G. Immunosuppressive Treatment With mTOR Inhibitors for Malignancies After Liver Transplantation: Long-Term Survival Retrospective Analysis. Transplant Proc 2020;52:1507-10. [PMID: 32213292 DOI: 10.1016/j.transproceed.2020.02.058] [Reference Citation Analysis]
165 de Boer JD, Putter H, Blok JJ, Alwayn IPJ, van Hoek B, Braat AE. Predictive Capacity of Risk Models in Liver Transplantation. Transplant Direct 2019;5:e457. [PMID: 31321293 DOI: 10.1097/TXD.0000000000000896] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
166 Nazzal M, Lentine KL, Naik AS, Ouseph R, Schnitzler MA, Zhang Z, Randall H, Dharnidharka VR, Segev DL, Kasiske BL, Hess GP, Alhamad T, McAdams-Demarco M, Axelrod DA. Center-driven and Clinically Driven Variation in US Liver Transplant Maintenance Immunosuppression Therapy: A National Practice Patterns Analysis. Transplant Direct 2018;4:e364. [PMID: 30046654 DOI: 10.1097/TXD.0000000000000800] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
167 Becchetti C, Dirchwolf M, Banz V, Dufour JF. Medical management of metabolic and cardiovascular complications after liver transplantation. World J Gastroenterol 2020; 26(18): 2138-2154 [PMID: 32476781 DOI: 10.3748/wjg.v26.i18.2138] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
168 Jeffrey AW, Delriviere L, McCaughan G, Crawford M, Angus P, Jones R, Macdonald GA, Fawcett J, Wigg A, Chen J, Gane E, Munn S, Jeffrey GP. Excellent Contemporary Graft Survival for Adult Liver Retransplantation: An Australian and New Zealand Registry Analysis From 1986 to 2017. Transplant Direct 2019;5:e472. [PMID: 31576368 DOI: 10.1097/TXD.0000000000000920] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
169 Mahmud N, Goldberg DS. Declining predictive performance of the MELD: Cause for concern or reflection of changes in clinical practice? Am J Transplant 2019;19:3221-2. [PMID: 31553133 DOI: 10.1111/ajt.15606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
170 Andres A, Oldani G, Berney T, Compagnon P, Line PD, Toso C. Transplantation for colorectal metastases: on the edge of a revolution. Transl Gastroenterol Hepatol. 2018;3:74. [PMID: 30363763 DOI: 10.21037/tgh.2018.08.04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
171 Jia JJ, Li JH, Yu H, Nie Y, Jiang L, Li HY, Zhou L, Zheng SS. Machine perfusion for liver transplantation: A concise review of clinical trials. Hepatobiliary Pancreat Dis Int. 2018;17:387-391. [PMID: 30352672 DOI: 10.1016/j.hbpd.2018.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
172 Yaron JR, Kwiecien JM, Zhang L, Ambadapadi S, Wakefield DN, Clapp WL, Dabrowski W, Burgin M, Munk BH, Mcfadden G, Chen H, Lucas AR. Modifying the Organ Matrix Pre-engraftment: A New Transplant Paradigm? Trends in Molecular Medicine 2019;25:626-39. [DOI: 10.1016/j.molmed.2019.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
173 Llop E, Iruzubieta P, Perelló C, Fernández Carrillo C, Cabezas J, Escudero MD, González M, Hernández Conde M, Puchades L, Arias-Loste MT, Serra MÁ, Crespo J, Calleja JL. High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort. United European Gastroenterol J 2021. [PMID: 34077628 DOI: 10.1002/ueg2.12109] [Reference Citation Analysis]
174 Oloruntoba OO, Moylan CA. "Too Female" for Liver Transplantation. Hepatology 2018;68:2424-5. [PMID: 29679376 DOI: 10.1002/hep.30053] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
175 Sakamoto H, Shirakigawa N, Bual RP, Fukuda Y, Nakamura S, Miyata T, Yamao T, Yamashita YI, Baba H, Ijima H. A novel evaluation system for whole-organ-engineered liver graft by ex vivo application to a highly reproducible hepatic failure rat model. J Artif Organs 2019;22:222-9. [PMID: 31076904 DOI: 10.1007/s10047-019-01106-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
176 Pavel M, Reyner E, Molina V, Garcia R, Ruiz A, Roque R, Diaz A, Fuster J, Garcia-valdecasas JC. Evolution Under Normothermic Machine Perfusion of Type 2 Donation After Cardiac Death Livers Discarded as Nontransplantable. Journal of Surgical Research 2019;235:383-94. [DOI: 10.1016/j.jss.2018.09.066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
177 Artzner T, Michard B, Weiss E, Barbier L, Noorah Z, Merle J, Paugam‐burtz C, Francoz C, Durand F, Soubrane O, Pirani T, Theocharidou E, O’grady J, Bernal W, Heaton N, Salamé E, Bucur P, Barraud H, Lefebvre F, Serfaty L, Besch C, Bachellier P, Schneider F, Levesque E, Faitot F. Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors. Am J Transplant 2020;20:2437-48. [DOI: 10.1111/ajt.15852] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
178 Titano J, Voutsinas N, Kim E. The Role of Radioembolization in Bridging and Downstaging Hepatocellular Carcinoma to Curative Therapy. Semin Nucl Med 2019;49:189-96. [PMID: 30954184 DOI: 10.1053/j.semnuclmed.2019.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
179 Maynard E. Liver Transplantation. Surgical Clinics of North America 2019;99:65-72. [DOI: 10.1016/j.suc.2018.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
180 Smith NK, Zerillo J, Kim SJ, Efune GE, Wang C, Pai SL, Chadha R, Kor TM, Wetzel DR, Hall MA, Burton KK, Fukazawa K, Hill B, Spad MA, Wax DB, Lin HM, Liu X, Odeh J, Torsher L, Kindscher JD, Mandell MS, Sakai T, DeMaria S Jr. Intraoperative Cardiac Arrest During Adult Liver Transplantation: Incidence and Risk Factor Analysis From 7 Academic Centers in the United States. Anesth Analg 2021;132:130-9. [PMID: 32167977 DOI: 10.1213/ANE.0000000000004734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
181 Sangineto M, Bukke VN, Bellanti F, Tamborra R, Moola A, Duda L, Villani R, Romano AD, Serviddio G. A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model. Nutrients 2021;13:652. [PMID: 33671262 DOI: 10.3390/nu13020652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
182 Gong N, Jia C, Huang H, Liu J, Huang X, Wan Q. Predictors of Mortality During Initial Liver Transplant Hospitalization and Investigation of Causes of Death. Ann Transplant 2020;25:e926020. [PMID: 33273447 DOI: 10.12659/AOT.926020] [Reference Citation Analysis]
183 Wehrman A, Waisbourd-Zinman O, Wells RG. Recent advances in understanding biliary atresia. F1000Res 2019;8:F1000 Faculty Rev-218. [PMID: 30828434 DOI: 10.12688/f1000research.16732.1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
184 Lee SG, Jeng LB, Saliba F, Singh Soin A, Lee WC, De Simone P, Nevens F, Suh KS, Fischer L, Jin Joo D, Fung J, Joh JW, Kaido T, Grant D, Meier M, Rauer B, Sips C, Kaneko S, Levy G. Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials. Transplantation 2021;105:1564-75. [PMID: 33741847 DOI: 10.1097/TP.0000000000003394] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Collins L, Quinn A, Stasko T. Skin Cancer and Immunosuppression. Dermatol Clin 2019;37:83-94. [PMID: 30466691 DOI: 10.1016/j.det.2018.07.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
186 Tang J, James L, Howell M, Tong A, Wong G. eHealth Interventions for Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Transplantation 2020;104:e224-35. [PMID: 32732828 DOI: 10.1097/TP.0000000000003294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Rubik J, Debray D, Kelly D, Iserin F, Webb NJA, Czubkowski P, Vondrak K, Sellier-Leclerc AL, Rivet C, Riva S, Tönshoff B, D'Antiga L, Marks SD, Reding R, Kazeem G, Undre N. Efficacy and safety of prolonged-release tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus - a Phase 2, open-label, single-arm, one-way crossover study. Transpl Int 2019;32:1182-93. [PMID: 31325368 DOI: 10.1111/tri.13479] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
188 Makri ES, Goulas A, Polyzos SA. Sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease. Eur J Pharmacol 2021;907:174272. [PMID: 34147478 DOI: 10.1016/j.ejphar.2021.174272] [Reference Citation Analysis]
189 Kitajima T, Moonka D, Yeddula S, Rizzari M, Collins K, Yoshida A, Abouljoud MS, Nagai S. Liver transplant waitlist outcomes in alcoholic hepatitis compared with other liver diseases: An analysis of UNOS registry. Clin Transplant 2020;34:e13837. [PMID: 32073688 DOI: 10.1111/ctr.13837] [Reference Citation Analysis]
190 Kim KM, Cho SS, Ki SH. Emerging roles of ferroptosis in liver pathophysiology. Arch Pharm Res 2020;43:985-96. [PMID: 33079307 DOI: 10.1007/s12272-020-01273-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
191 Rikhi R, Singh T, Modaresi Esfeh J. Work up of fatty liver by primary care physicians, review. Ann Med Surg (Lond) 2020;50:41-8. [PMID: 31993196 DOI: 10.1016/j.amsu.2020.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Pettinato G, Lehoux S, Ramanathan R, Salem MM, He LX, Muse O, Flaumenhaft R, Thompson MT, Rouse EA, Cummings RD, Wen X, Fisher RA. Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells. Sci Rep. 2019;9:8920. [PMID: 31222080 DOI: 10.1038/s41598-019-45514-3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 17.7] [Reference Citation Analysis]
193 González IA, Hartley CP, Nalbantoglu I. Recurrent Autoimmune Hepatitis and De Novo Autoimmune Hepatitis in the Liver Allograft. Am J Clin Pathol 2021;155:435-45. [PMID: 33252121 DOI: 10.1093/ajcp/aqaa147] [Reference Citation Analysis]
194 Cortez AR, Morris MC, Brown NG, Winer LK, Safdar K, Poreddy S, Shah SA, Quillin RC 3rd. Is Surgery Necessary? Endoscopic Management of Post-transplant Biliary Complications in the Modern Era. J Gastrointest Surg 2020;24:1639-47. [PMID: 31228080 DOI: 10.1007/s11605-019-04292-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 Ji E, Kim MG, Oh JM. CYP3A5 genotype-based model to predict tacrolimus dosage in the early postoperative period after living donor liver transplantation. Ther Clin Risk Manag 2018;14:2119-26. [PMID: 30498355 DOI: 10.2147/TCRM.S184376] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
196 Cotter TG, Paul S, Sandıkçı B, Couri T, Bodzin AS, Little EC, Sundaram V, Charlton M. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)‐Viremic Donors Into HCV‐Negative Recipients: Outcomes Following Liver Transplant of HCV‐Viremic Donors. Hepatology 2019. [DOI: 10.1002/hep.30540] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
197 Kalisvaart M, Croome KP, Hernandez-Alejandro R, Pirenne J, Cortés-Cerisuelo M, Miñambres E, Abt PL. Donor Warm Ischemia Time in DCD Liver Transplantation-Working Group Report From the ILTS DCD, Liver Preservation, and Machine Perfusion Consensus Conference. Transplantation 2021;105:1156-64. [PMID: 34048418 DOI: 10.1097/TP.0000000000003819] [Reference Citation Analysis]
198 Ruiz MM, Alobaidi R, Noga ML, Featherstone R, Shapiro J, Bhargava R. Doppler ultrasound values after liver transplantation in children and their association with graft outcomes: a protocol for a systematic review and meta-analysis. BMJ Open 2019;9:e033887. [PMID: 31826898 DOI: 10.1136/bmjopen-2019-033887] [Reference Citation Analysis]
199 Giard J, Dodge JL, Terrault NA. Superior Wait‐List Outcomes in Patients with Alcohol‐Associated Liver Disease Compared With Other Indications for Liver Transplantation. Liver Transpl 2019;25:1310-20. [DOI: 10.1002/lt.25485] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
200 Ge J, Hsu EK, Bucuvalas J, Lai JC. Deceased Pediatric Donor Livers: How Current Policy Drives Allocation and Transplantation. Hepatology 2019;69:1231-41. [PMID: 30281806 DOI: 10.1002/hep.30295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
201 Swenson SM, Roberts JP, Rhee S, Perito ER. Impact of the Pediatric End-Stage Liver Disease (PELD) growth failure thresholds on mortality among pediatric liver transplant candidates. Am J Transplant 2019;19:3308-18. [PMID: 31370108 DOI: 10.1111/ajt.15552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
202 Tapper EB, Wexler R, Goldman E, Volk M. Constitutional Challenges to Liver Transplant Policy. Transplantation 2019;103:e378-81. [PMID: 31259856 DOI: 10.1097/TP.0000000000002703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
203 Cotter TG, Paul S, Sandıkçı B, Couri T, Bodzin AS, Little EC, Sundaram V, Charlton M. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era. Liver Transpl 2019;25:598-609. [PMID: 30716208 DOI: 10.1002/lt.25424] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
204 Park B, Yoon J, Choi D, Kim HJ, Jung YK, Kwon OJ, Lee KG. De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data. Sci Rep 2019;9:17202. [PMID: 31748582 DOI: 10.1038/s41598-019-53163-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
205 Maue DK, Mangus RS, Lutfi R, Hobson MJ, Rao GS, Nitu ME, Abu-Sultaneh S. Practice variation in the immediate postoperative care of pediatric liver transplant patients: Framework for a national consensus. Pediatr Transplant 2021;25:e13976. [PMID: 33502816 DOI: 10.1111/petr.13976] [Reference Citation Analysis]
206 Cousino MK, Schumacher KR, Magee JC, Wolfe J, Yu S, Eder SJ, Fredericks EM. Communication about prognosis and end‐of‐life in pediatric organ failure and transplantation. Pediatr Transplant 2019;23. [DOI: 10.1111/petr.13373] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
207 Shen NT, Wu A, Farrell K, Ivatorov A, Dawod E, Raver M, Russo N, Robbins L, Safford M, Brown RS Jr. Patient Perspectives of High-Quality Care on the Liver Transplant Waiting List: A Qualitative Study. Liver Transpl 2020;26:238-46. [PMID: 31553123 DOI: 10.1002/lt.25645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
208 Valentino PL, Emre S, Geliang G, Li L, Deng Y, Mulligan D, Rodriguez-Davalos MI. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: Children experienced increased wait time and death. Am J Transplant 2019;19:3114-23. [PMID: 31152483 DOI: 10.1111/ajt.15481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
209 Park J, Kim JH, Kim JE, Park SJ, Yi NJ, Han JK. Prediction of liver regeneration in recipients after living-donor liver transplantation in using preoperative CT texture analysis and clinical features. Abdom Radiol (NY) 2020;45:3763-74. [PMID: 32296898 DOI: 10.1007/s00261-020-02518-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
210 Prusinskas B, Ohlsson S, Kathemann S, Pilic D, Kampmann K, Büscher R, Paul A, Pape L, Hoyer PF, Lainka E. Role of Tacrolimus C/D Ratio in the First Year After Pediatric Liver Transplantation. Front Pediatr 2021;9:659608. [PMID: 34150686 DOI: 10.3389/fped.2021.659608] [Reference Citation Analysis]
211 Pinezich M, Vunjak-Novakovic G. Bioengineering approaches to organ preservation ex vivo. Exp Biol Med (Maywood) 2019;244:630-45. [PMID: 30889963 DOI: 10.1177/1535370219834498] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
212 Douglas SJ, Remily EA, Sax OC, Pervaiz SS, Mohamed NS, Kelemen MN, Delanois RE, Johnson AJ. Primary total hip arthroplasty complications and costs in liver transplant recipients: a matched analysis using a national database. Hip Int 2021;:11207000211037225. [PMID: 34748455 DOI: 10.1177/11207000211037225] [Reference Citation Analysis]
213 Likhitsup A, Hassan A, Mellinger J, Askari F, Winder GS, Saeed N, Sonnenday CJ, Sharma P, Fontana RJ. Impact of a Prohibitive Versus Restrictive Tobacco Policy on Liver Transplant Candidate Outcomes. Liver Transpl 2019. [DOI: 10.1002/lt.25497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
214 Jha SK, Chaudhary A. Comment on "Minimally Invasive Donor Hepatectomy for Adult Living Donor Liver Transplantation". Ann Surg 2021;274:e820-1. [PMID: 32941288 DOI: 10.1097/SLA.0000000000004504] [Reference Citation Analysis]
215 Sun L, Marsh JN, Matlock MK, Chen L, Gaut JP, Brunt EM, Swamidass SJ, Liu TC. Deep learning quantification of percent steatosis in donor liver biopsy frozen sections. EBioMedicine. 2020;60:103029. [PMID: 32980688 DOI: 10.1016/j.ebiom.2020.103029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
216 Pavel M, Reyner E, Fuster J, Garcia-valdecasas JC. Trasplante hepático con injerto de donante en asistolia tipo 2 con perfusión regional normotérmica y máquina de perfusión normotérmica. Cirugía Española 2018;96:508-13. [DOI: 10.1016/j.ciresp.2018.06.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
217 Wiseman AC. Simultaneous Liver-Kidney Transplant: Long-Term Management (Steroid Withdrawal and Safety Net Patients). Clin Liver Dis (Hoboken) 2019;13:176-9. [PMID: 31316765 DOI: 10.1002/cld.814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
218 Tubben A, Sotomayor CG, Post A, Minovic I, Frelink T, de Borst MH, Said MY, Douwes RM, van den Berg E, Rodrigo R, Berger SP, Navis GJ, Bakker SJL. Urinary Oxalate Excretion and Long-Term Outcomes in Kidney Transplant Recipients. J Clin Med 2019;8:E2104. [PMID: 31810202 DOI: 10.3390/jcm8122104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
219 Gravesteijn B, Krijkamp E, Busschbach J, Geleijnse G, Helmrich IR, Bruinsma S, van Lint C, van Veen E, Steyerberg E, Verhoef K, van Saase J, Lingsma H, Baatenburg de Jong R; Value Based Operation Room Triage team collaborators. Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study. Value Health 2021;24:648-57. [PMID: 33933233 DOI: 10.1016/j.jval.2020.12.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
220 Balaceanu A. Deep vein thrombosis during long-term surveillance of patients with liver transplantation. Ir J Med Sci 2019;188:1191-3. [DOI: 10.1007/s11845-019-01998-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
221 Costentin CE, Bababekov YJ, Zhu AX, Yeh H. Is It Time to Reconsider the Milan Criteria for Selecting Patients With Hepatocellular Carcinoma for Deceased-Donor Liver Transplantation? Hepatology 2019;69:1324-36. [DOI: 10.1002/hep.30278] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]